Covalon Technologies Ltd. (COV) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.218x

Based on the latest financial reports, Covalon Technologies Ltd. (COV) has a cash flow conversion efficiency ratio of 0.218x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$5.75 Million ≈ $4.16 Million USD) by net assets (CA$26.39 Million ≈ $19.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Covalon Technologies Ltd. (COV) total market value for the company's overall valuation and market capitalisation.

Covalon Technologies Ltd. - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Covalon Technologies Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Covalon Technologies Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Covalon Technologies Ltd. ranked by their cash flow conversion efficiency. Explore Covalon Technologies Ltd. (COV) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Donkeyrepublic Holding AS
CO:DONKEY
0.036x
Hotelim Société Anonyme
PA:MLHOT
N/A
Pangaea Oncology S.A.
MC:PANG
-0.057x
5E ADVANCED MATLS NEW
F:J9I1
-0.101x
LightInTheBox Holding Co Ltd ARD
NYSE:LITB
-2.224x
META WOLF AG INH O.N.
F:WOLF
N/A
Patria Latin American Opportunity
NASDAQ:PLAO
-0.009x
TLGY Acquisition Corp
NASDAQ:TLGY
0.026x

Annual Cash Flow Conversion Efficiency for Covalon Technologies Ltd. (2005–2025)

The table below shows the annual cash flow conversion efficiency of Covalon Technologies Ltd. from 2005 to 2025. View current stock price of Covalon Technologies Ltd. for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-09-30 CA$30.73 Million
≈ $22.23 Million
CA$2.29 Million
≈ $1.66 Million
0.075x -41.00%
2024-09-30 CA$27.50 Million
≈ $19.90 Million
CA$3.47 Million
≈ $2.51 Million
0.126x +174.53%
2023-09-30 CA$18.79 Million
≈ $13.59 Million
CA$-3.18 Million
≈ $-2.30 Million
-0.169x +48.65%
2022-09-30 CA$24.23 Million
≈ $17.53 Million
CA$-7.99 Million
≈ $-5.78 Million
-0.330x -1872.06%
2021-09-30 CA$33.37 Million
≈ $24.14 Million
CA$621.37K
≈ $449.49K
0.019x +104.21%
2020-09-30 CA$9.11 Million
≈ $6.59 Million
CA$-4.03 Million
≈ $-2.91 Million
-0.442x -133.57%
2019-09-30 CA$14.93 Million
≈ $10.80 Million
CA$-2.83 Million
≈ $-2.04 Million
-0.189x -278.94%
2018-09-30 CA$13.12 Million
≈ $9.49 Million
CA$-655.47K
≈ $-474.16K
-0.050x -3061.17%
2017-09-30 CA$8.98 Million
≈ $6.50 Million
CA$15.15K
≈ $10.96K
0.002x +100.63%
2016-09-30 CA$3.81 Million
≈ $2.75 Million
CA$-1.03 Million
≈ $-742.05K
-0.269x +43.16%
2015-09-30 CA$4.79 Million
≈ $3.46 Million
CA$-2.27 Million
≈ $-1.64 Million
-0.474x -184.43%
2014-09-30 CA$5.53 Million
≈ $4.00 Million
CA$3.10 Million
≈ $2.24 Million
0.561x +211.29%
2013-09-30 CA$2.95 Million
≈ $2.13 Million
CA$-1.49 Million
≈ $-1.07 Million
-0.504x +50.18%
2012-09-30 CA$3.23 Million
≈ $2.34 Million
CA$-3.27 Million
≈ $-2.37 Million
-1.012x -113.61%
2011-09-30 CA$7.02 Million
≈ $5.07 Million
CA$-3.32 Million
≈ $-2.40 Million
-0.474x -6063.75%
2010-09-30 CA$7.57 Million
≈ $5.48 Million
CA$-58.20K
≈ $-42.10K
-0.008x +98.20%
2009-09-30 CA$10.94 Million
≈ $7.91 Million
CA$-4.67 Million
≈ $-3.38 Million
-0.427x -131.81%
2008-09-30 CA$15.02 Million
≈ $10.86 Million
CA$-2.76 Million
≈ $-2.00 Million
-0.184x -2114.69%
2007-09-30 CA$17.59 Million
≈ $12.73 Million
CA$-146.21K
≈ $-105.77K
-0.008x +97.04%
2006-09-30 CA$8.27 Million
≈ $5.98 Million
CA$-2.32 Million
≈ $-1.68 Million
-0.281x -13.16%
2005-09-30 CA$3.79 Million
≈ $2.74 Million
CA$-941.80K
≈ $-681.28K
-0.248x --

About Covalon Technologies Ltd.

V:COV Canada Medical Instruments & Supplies
Market Cap
$69.13 Million
CA$95.56 Million CAD
Market Cap Rank
#21716 Global
#763 in Canada
Share Price
CA$3.46
Change (1 day)
-3.89%
52-Week Range
CA$1.56 - CA$3.60
All Time High
CA$9.18
About

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more